Inactive Instrument

HEAH SCIE

Equities

HSAQ

KYG4411D1097

Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

November 13, 2021 at 02:46 am IST

Health Sciences Acquisitions Corporation 2 reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 0.090411 million compared to USD 0.066214 million a year ago. For the nine months, net loss was USD 0.290742 million. Basic loss per share from continuing operations was USD 0.01.

Latest news about HEAH SCIE

Insider Buy: Health Sciences Acquisitions Corp 2	27/23/27	MT
Health Sciences Acquisitions Corporation 2(NasdaqCM:HSAQ) dropped from NASDAQ Composite Index	26/23/26	CI
Orchestra BioMed, Inc. completed the acquisition of Health Sciences Acquisitions Corporation 2 from HSAC 2 Holdings, LLC, RTW Investments, LP and others in a reverse merger transaction.	26/23/26	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Full Year Ended December 31, 2022	26/23/26	CI
Health Sciences Acquisitions Corporation 2 Auditor Raises 'Going Concern' Doubt	25/23/25	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/22/15	CI
Insider Buy: Health Sciences Acquisitions Corp 2	25/22/25	MT
Orchestra BioMed, Health Sciences Acquisitions Corp. to Merge; Combined Company to be Listed on Nasdaq	05/22/05	MT
Orchestra BioMed, Inc. entered into an agreement and plan of merger agreement to acquire Health Sciences Acquisitions Corporation 2 from HSAC 2 Holdings, LLC, RTW Investments, LP and others for $93 million.	05/22/05	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Health Sciences Acquisitions Corporation 2 Auditor Raises 'Going Concern' Doubt	31/22/31	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	13/21/13	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17	CI
Health Sciences Acquisitions Corporation 2 Reports Earnings Results for the First Quarter Ended March 31, 2021	18/21/18	CI
Health Sciences Acquisitions Corporation 2 announced that it has received $6 million in funding from HSAC 2 Holdings, LLC	06/20/06	CI
Health Sciences Acquisitions Corporation 2 has completed an IPO in the amount of $139.13044 million.	04/20/04	CI
Health Sciences Acquisitions Corporation 2 announced that it expects to receive $6 million in funding from Hsac 2 Holdings, Llc	03/20/03	CI
Health Sciences Acquisitions Corporation 2 has filed an IPO in the amount of $125 million.	17/20/17	CI

Chart HEAH SCIE

Duration

Period

More charts

Company Profile

Health Sciences Acquisitions Corporation 2 is a blank check company. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It intends to target companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. It has generated no revenues.

Sector

More about the company